Q32 Bio Inc.
financial.report · SEC EDGAR
This page reproduces a recorded source event. It is not a live quote, forecast, recommendation or legal conclusion.
Event type
financial.report
Occurred
2026-03-31
Reported
2026-05-05
Disclosure lag
35 days
Context
links are based on the recorded entity type| Field | Recorded value |
|---|---|
| Entity | Q32 Bio Inc. |
| Source | SEC EDGAR ↗ |
| Source identifier | companyfacts/CIK0001661998/2026-07-26 |
| Event ID | #29089 |
Recorded payload
JSON payload as stored after parsing{
"accession": "0001193125-26-205021",
"canonical_covered": 11,
"canonical_total": 12,
"fiscal_period": "Q1",
"fiscal_year": 2026,
"form": "10-Q",
"mapped_tag_share": 0.047021943573667714,
"metrics": {
"cash_and_equivalents": 50751000,
"earnings_per_share_basic": -0.54,
"earnings_per_share_diluted": -0.54,
"net_income": -7609000,
"operating_cash_flow": -6343000,
"operating_income": -7722000,
"shareholders_equity": 46313000,
"shares_outstanding": 14629463,
"total_assets": 63675000,
"total_liabilities": 17362000
},
"metrics_reported": 10,
"period_end": "2026-03-31"
}Source: SEC EDGAR · as of 2026-05-05T00:00:00Z